Attovia Therapeutics’ biologic medicines could offer advantages over currently available immune disorder drugs, such as Sanofi’s blockbuster medicine Dupixent. The IPO comes as Attovia looks to expand clinical development of its pipeline in 2027. The post Attovia’s Upsized IPO Brings In $289M to Fund New Kind of Biologic for Immune Disorders appeared first on MedCity News.

Despite the silk masks, oils, and sleepy girl mocktails swirling around social media, one of the greatest causes of non-restorative sleep is rarely mentioned by wellness influencers online: actual sleep disorders. The post The Sleep Crisis We May Be Missing: Why Millions of Americans Remain Undiagnosed  appeared first on MedCity News.

Healthcare leaders who shape that future need more than innovation. They need a visible, credible voice that helps the people around them — patients, clinicians, employees, partners, and investors — understand what the change is, why it matters, and why this is the right person to lead it. The post The Healthcare Leaders Driving Change Need to Get Better at Explaining It appeared first on MedCity News.

QuantHealth raised $45 million in Series B funding to expand its AI platform, which simulates clinical trials before they run and predicts patient outcomes for pharma companies. The startup is aiming to cut the industry’s 90% trial failure rate and speed up the timelines for effective drugs to reach the market. The post QuantHealth Snags $45M to Simulate Clinical Trials Before Patients Ever Enroll appeared first on MedCity News.

The American College of Physicians is urging policymakers to expand access to obesity treatment and healthy foods while investing in prevention and research. The post How Policymakers Can Improve Obesity Treatment and Affordability, Per American College of Physicians appeared first on MedCity News.

Pathos AI struck a deal for rights to a bispecific antibody drug conjugate from Alphamab that could become first in a new class of cancer drugs. Separately, the startup began a partnership with AstraZeneca on a protein degrader from the pharma company’s cancer drug pipeline. The post Pathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents appeared first on MedCity News.

The future of health care innovation is technology that carries more of the load, so people don’t have to. The post Health Tech Promised Simplicity — Why Does It Feel Like More Work? appeared first on MedCity News.

[Sponsored] What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes. The post From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS appeared first on MedCity News.

The gap between what technology can do and how much patients trust it won’t close on its own. Here are some design decisions that build trust — and some that quietly destroy it. The post The Trust Gap in Digital Health and AI Starts With Design — Here’s How to Close It appeared first on MedCity News.

HHS is reviving a rebate program for 340B drug discounts after the previous pilot was blocked in court earlier this year. Providers say the change will burden already cash-strapped providers with new administrative and financial costs. The post HHS Is Reviving Its 340B Rebate Push — And Providers Are None Too Pleased appeared first on MedCity News.

An Elevance Health Public Policy Institute study found rural patients used telehealth less than non-rural patients across all chronic conditions and insurance types. The post Report: Telehealth Uptake Is Lagging in Rural Areas appeared first on MedCity News.

M&A activity is going beyond big pharma acquisitions with Supernus Pharmaceuticals and Indivior Pharmaceuticals reaching a stock deal that the companies call a merger of equals. The combined company’s portfolio will have 11 commercialized products in addiction, attention-deficit hyperactivity disorder, depression, and Parkinson’s disease. The post Supernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company appeared first on MedCity News.

Ethical AI and trustworthy AI frameworks should be table stakes for healthcare and life sciences organizations seeking to innovate with AI. The post From Ethics to Trust: Strategic Guardrails for Safe, Secure, Effective AI in Healthcare appeared first on MedCity News.

The products that succeed over time are usually the ones that make life easier, fit naturally into existing routines and continue delivering value long after the novelty wears off. The post Beyond Adoption: The Habits Shaping Digital Health appeared first on MedCity News.

Sentara Health notified Anthem that it will let its commercial, Medicare and Medicaid contracts expire at year’s end unless the two sides reach a new rate agreement. The dispute puts coverage for an estimated 380,000 Virginians at risk. The post ‘We’re Not Going to Be Bullied’: Sentara Digs in on Anthem Contract Fight  appeared first on MedCity News.